Immuneering (IMRX) Return on Equity [ROE] (2021 - 2026)
Immuneering (IMRX) reported Return on Equity [ROE] of -29.58% for Q2 2026, up 146.60 percentage points from -176.18% a year earlier but down 3.57 percentage points from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Immuneering posted Return on Equity [ROE] of -43.36%, up 49.82 percentage points from FY2024.
- Return on Equity [ROE] has a four-year change of +6.88 percentage points (FY2021 to FY2025).
- By year, Return on Equity [ROE] came in at -93.18% in FY2024 (-38.49 pp), -54.69% in FY2023 (-16.68 pp), -38.00% in FY2022 (+12.24 pp) and -50.24% in FY2021.
- Five-year quarterly Return on Equity [ROE] spans a low of -176.18% in Q2 2025 and a high of -21.46% in Q4 2021.
- Year over year, Return on Equity [ROE] has now increased in each of the last four quarters, with an average year-over-year change of +14.92 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2026 (a gain of 146.60 percentage points); the low point was Q2 2025 (a drop of 97.26 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -26.01% (Q1 2026), -25.24% (Q4 2025) and -48.72% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Immuneering | 264.61 Mn | 264.61 Mn | - | -29.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.58% |
| Mar 31, 2026 | -26.01% |
| Dec 31, 2025 | -25.24% |
| Sep 30, 2025 | -48.72% |
| Jun 30, 2025 | -176.18% |
| Mar 31, 2025 | -148.99% |
| Dec 31, 2024 | -124.06% |
| Sep 30, 2024 | -94.95% |
| Jun 30, 2024 | -78.92% |
| Mar 31, 2024 | -65.54% |
| Dec 31, 2023 | -56.33% |
| Sep 30, 2023 | -48.13% |
| Jun 30, 2023 | -49.43% |
| Mar 31, 2023 | -49.88% |
| Dec 31, 2022 | -43.78% |
| Sep 30, 2022 | -37.76% |
| Jun 30, 2022 | -31.55% |
| Mar 31, 2022 | -26.85% |
| Dec 31, 2021 | -21.46% |
| Sep 30, 2021 | -46.43% |
API Access
Immuneering Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();